Nurse-led skin cancer screening extends specialist reach but depends on the nurse selecting which lesions to forward for diagnosis, and performance varies with experience. We evaluated whether real-time decision support using artificial intelligence (AI) improves malignancy detection in routine nurse-led teledermoscopy screening across MoleMap clinics in New Zealand and Australia (January 2024-July 2025). In this real-world study, clinics using AI decision support were compared with standard clinics.
AI-assisted nurse-led skin cancer screening in a teledermoscopy framework: a multi-site evaluation with one million lesions
calendar_today
October 2, 2026
person
Shaik, N. E. K., Desai, N., Wang, K., Wild, L., Dunn, A. G., Oakley, A., Palaniswami, M., Vendrig, J.
domain
medrxiv